2017 Summit Speakers

Keynote address by Albert Starr, M.D., Lasker Award Winner

Albert Starr, M.D., is a pioneering cardiovascular surgeon who co-invented and successfully implanted the world’s first artificial heart valve. The groundbreaking Starr-Edwards heart valve has saved and prolonged the lives of hundreds of thousands of people around the world. Starr resides in Portland, Oregon, and is a distinguished professor of cardiovascular medicine and chairman of the OHSU Knight Cardiovascular Institute at Oregon Health & Science University.

Read full bio

Christie Ballantyne, M.D.

PCSK9 inhibition: promise fulfilled?
Friday, Sept. 8 | 10:20 a.m.

Dr. Ballantyne is a professor of medicine and chief of cardiology and cardiovascular research at Baylor College of Medicine. He is also director of the Center for Cardiovascular Disease Prevention at Houston Methodist DeBakey Heart & Vascular Center.

Christie Ballantyne is one of the nation’s foremost experts on cholesterol, statins and heart disease prevention. His research interest in the prevention of heart disease has led him to become an established investigator for the American Heart Association. Additionally, he has several National Institutes of Health (NIH) grants to study leukocyte-endothelial adhesion molecules and novel markers for atherosclerosis.

Over the past 34 years, his many accomplishments have included being honored as fellow of the American Association for the Advancement of Science, the American College of Cardiology and the American College of Physicians. In 2014, Thomson Reuters also recognized Christie as one of “The World’s Most Influential Scientific Minds.”

With over 600 publications in the area of atherosclerosis, lipids and inflammation, Christie also serves as an editorial director for www.lipidsonline.org as well as associate editor for Circulation and the Journal of Cardiovascular Risk.

Christie received his M.D. from Baylor College of Medicine and performed both his internal medicine residency and postgraduate training at The University of Texas Southwestern Medical School. He completed a cardiology fellowship at Baylor College of Medicine and an American Heart Association/Bugher Foundation Fellowship at the Howard Hughes Medical Institute and Institute for Molecular Genetics at Baylor.

See More

Michael Blaha, M.D., M.P.H.

Providing evidence for subclinical atherosclerosis in risk assessment
Friday, Sept. 8 | 11 a.m.

Dr. Michael J. Blaha currently serves as the director of clinical research for the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease. He is an associate editor for the journal Atherosclerosis, associate editor for the Diabetes and Cardiometabolic Clinical Community on acc.org, and is a standing member of the Endocrinologic and Metabolic Drug Advisory Committee (EMDAC) for the FDA.

He has participated in advisory boards for many leading pharmaceutical companies in the cardiometabolic space. He serves on both the Statistics Committee and the Early Career Committee for the American Heart Association (AHA), as well as the Publications and Presentations Committee for the Multi-Ethnic Study of Atherosclerosis (MESA). He is co-chair of the Cross Cohort Collaboration, which seeks to combine data from all ongoing prospective epidemiologic cohorts.

In 2010, Dr. Blaha was given a Young Investigator Award from MESA for work published in The Lancet. In 2013, he was given a second Young Investigator Award from MESA for work published in the European Heart Journal. Dr. Blaha’s work in MESA has been published in such journals as Circulation, Journal of the American College of Cardiology, JAMA, American Journal of Epidemiology, JACC Cardiovascular Imaging, and Atherosclerosis, among others.

He has received multiple grant awards from the National Institutes of Health, Food and Drug Administration, American Heart Association, Amgen, and the Aetna Foundation.

Dr. Blaha has published over 250 original papers and has published two books on the metabolic syndrome. He has mentored over 20 trainees and has delivered grand rounds lectures at over 10 institutions. Dr. Blaha is a founding member of The FIT Project, is a principal investigator of the Coronary Artery Calcium Consortium and is co-director of the mobile health mActive Program at Johns Hopkins.

Clinically, he practices as a preventive noninvasive cardiologist and in the interpretation of cardiac CT.

See More

Mark Creager, M.D.

Peripheral vascular disease: it’s a matter of life and limb
Saturday, Sept. 9 | 8:40 a.m.

Dr. Mark A. Creager is a professor of medicine and surgery at the Geisel School of Medicine at Dartmouth, and director of the Heart and Vascular Center at Dartmouth-Hitchcock Medical Center in Lebanon, N.H. Dr. Creager earned his medical degree at Temple University in Philadelphia. He completed his internship, medical residency and fellowships in vascular medicine and cardiology at University Hospital in Boston.

Dr. Creager is immediate past president of the American Heart Association and serves on its National Board of Directors. He is an editor of the textbook Vascular Medicine and the editor emeritus of the journal Vascular Medicine. He is a past president of the Vascular Disease Foundation and a past president and master of the Society for Vascular Medicine. He is a fellow of the American Heart Association and the American College of Cardiology, and a member of the American Society of Clinical Investigation. His major research and clinical interest is in vascular medicine, specifically vascular regulatory mechanisms and the effect of treatment on patients with peripheral artery disease. He is the author of more than 350 published contributions to the medical literature, including research papers on vascular function, book chapters, and monographs on vascular disease. Dr. Creager has been recognized with several prestigious awards and honors, including the Vascular Disease Foundation President’s Award for Leadership and the American Heart Association Council on Peripheral Vascular Disease Distinguished Achievement Award, and the American Heart Association Distinguished National Leadership Award.

See More

Brian DeRubertis, M.D., F.A.C.S.

Spectrum of PAD therapies – who, when and how?
Saturday, Sept. 9 | 9:20 a.m.

Dr. DeRubertis is an associate professor of surgery at UCLA Medical Center in Los Angeles.  He received his doctorate degree in medicine at Weill Medical College of Cornell University in New York and completed his surgical residency at New York Hospital-Cornell Medical Center and then a vascular and endovascular surgery fellowship with the Division of Vascular Surgery of Cornell University and Columbia College of Physicians and Surgeons at New York Presbyterian Hospital. He is board certified in General Surgery and Vascular Surgery, and his surgical practice and clinical research efforts focus on the endovascular and open surgical management of many complex vascular issues.   

He joined the Division of Vascular Surgery at the David Geffen School of Medicine at UCLA in 2007, and is an attending surgeon at the UCLA Ronald Regan Medical Center and at the UCLA-Santa Monica Medical Center. His administrative duties include those as Medical Director of the UCLA Gonda Ambulatory Procedure Unit and Vascular Representative on the UCLA-Ronald Regan Medical Center Interventional Director. His current surgical practice involves the application of the newest minimally invasive technology for the treatment of complex aortic aneurysms, peripheral arterial disease of the carotid arteries and lower extremities, and venous disorders including deep venous thrombosis, Paget-Schroetter’s Syndrome, and May-Thurner’s Syndrome. He has a particular interest in innovative device technology, and has introduced the practice of percutaneous EVAR and the use of fenestrated aortic endografts to his institution.   

He has presented more than 35 scientific abstracts at major surgical and interventional meetings, including the American Surgical Association, the Vascular Annual Meeting of the Society for Vascular Surgery, the Eastern Vascular Society, the Western Vascular Society, The VEITH Symposium, and the Leipzig Interventional Conference (LINC). He has given over 130 invited lectures both nationally and internationally, and has authored or co-authored 13 book chapters and more than 65 peer-reviewed publications.

His primary research efforts are focused on clinical trials for lower extremity occlusive disease and carotid stenting. He is a national Co-Principal investigator on the REALITY Trial, and has participated as principal investigator or co-investigator on over a dozen clinical trials, including the current NIH-funded BEST-CLI Trial for lower extremity revascularization. He is an active member of multiple surgical societies, including the Society for Vascular Surgery, the Western Vascular Society, the Pacific Coast Surgical Society, and the Vascular and Endovascular Surgery Society, among others, and has served as Co-Director of the Peripheral Vascular Course at the annual Transcatheter Therapeutics Conference. 

See More

Marcelo DiCarli, M.D.

Coronary microvascular dysfunction in ischemic heart disease: implications for diagnosis and management
Friday, Sept. 8 | 1 p.m.

Dr. DiCarli is the Chief of Nuclear Medicine at Brigham and Women's Hospital and a Professor of Radiology and Medicine. His research and clinical interests are positron emission tomography (PET), myocardial blood flow and metabolism, and cardiac autonomic function. He received his medical degree from University of Buenos Aires, Argentina.

He completed his residency in Internal Medicine and fellowship in Cardiovascular Disease at the Institute of Cardiology and Cardiovascular Surgery Favaloro Foundation in Buenos Aires, Argentina. Followed by a research fellowship in Cardiovascular Nuclear Medicine and clinical fellowship in Nuclear Medicine at UCLA School of Medicine in Los Angeles, CA. 

See More

Mariell Jessup, M.D., F.A.H.A., F.A.C.C., F.E.S.C.

Acute Heart Failure: Management, Pearls, and Lessons Learned
Friday, Sept. 8 | 9:20 a.m.

Dr. Mariell Jessup is the inaugural Chief Scientific Officer of the Foundation Leducq.

Dr. Jessup is an Emeritus Professor of Medicine at the University of Pennsylvania’s Perelman School of Medicine where she also served as the Medical Director of Penn’s Heart and Vascular Center and Clinical Chief of the Cardiovascular Division until July 2015. 

Dr. Jessup’s focus throughout her career has been translating new therapies for and the optimal management of patients with heart failure, including the appropriate selection of patients for heart transplant or ventricular assist devices (VADs). The foundation for these clinical activities continues to be discovery science and clinical trials.

Dr. Jessup has been a long-time volunteer of the American Heart Association (AHA), having served as the Chair of the Committee for Scientific Sessions Program, and as a member of the Board of Directors of the national AHA, before becoming President of the American Heart Association in 2013.

In addition to publishing numerous articles, editorials, reviews, and chapters on heart failure and heart transplant, Dr. Jessup was a clinical investigator in many landmark clinical trials in heart failure. For example, she led the first-in-man study using the gene for SERCA2A.

See More

Samir Kapadia, M.D.

Aortic valve: TAVR: standard care of the future or a promise unfulfilled
Friday, Sept. 8 | 3:20 p.m.

Samar Kapadia, M.D., is the section head of invasive and interventional cardiology, director of the Sones Cardiac Catheterization Laboratories and director of the Interventional Cardiology Fellowship Program at the Arnold Miller Family Heart & Vascular Institute at the Cleveland Clinic. He is a professor of medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Dr. Kapadia is board-certified in internal medicine, cardiology and interventional cardiology.

Dr. Kapadia has a special interest in coronary interventions, percutaneous treatment of valvular heart disease, ASD/PFO closure, and carotid and peripheral interventions. He has performed more than 1,000 TAVR procedures and thousands of other cardiovascular procedures throughout his career.

Dr. Kapadia received his medical degree with honors from Smt. NHL Municipal Medical College in Gujarat, India. He completed his internship and residency in internal medicine at Baylor College of Medicine in Houston, Texas, where he was named Outstanding Resident. Dr. Kapadia completed fellowships in cardiology and interventional cardiology at Cleveland Clinic, and was named chief interventional fellow.

Prior to his appointment to Cleveland Clinic, Dr. Kapadia had an academic appointment to the Department of Medicine at the University of Washington, Seattle, and was an interventional cardiologist at the VA Puget Sound Health Care System, Seattle. Dr. Kapadia has published more than 300 articles and abstracts in professional scientific journals and has patented various devices for percutaneous valve treatments.

See More


Dhanunjaya Lakkireddy, M.D., F.A.C.C., F.H.R.S.

Left atrial appendage closure — state of the art
Saturday, Sept. 9 | 10:20 a.m.

Professor Dhanunjaya (DJ) Lakkireddy is director of the Center for Excellence in AF and Complex Arrhythmias at the University of Kansas Hospital and is board certified in cardiology and electrophysiology. He is an internationally renowned electrophysiologist whose contributions have helped advance the field of cardiology.

Dr. Lakkireddy has more than 250 peer-reviewed articles and abstracts to his credit. He has been the primary investigator for over 100 investigator-initiated studies and industry-sponsored trials that have expanded the scope of clinical practice in cardiology and electrophysiology. He was the lead investigator of the “YOGA MY HEART” study, internationally recognized for its innovation in exploring alternative medical strategies as a supplement to standard medical therapy. He received the Prevention Award for the year 2011 for his contributions to cardiovascular health from Prevention magazine. He was recognized by Ingram’s magazine with a Heroes in Medicine award in 2014.

Dr. Lakkireddy is the program director for the Kansas City Heart Rhythm Symposium. He co-directs the International Symposium on Left Atrial Appendage, focused on the frontier science of left atrial appendage. In addition, he is the founder of Global Atrial Fibrillation Alliance, a not-for-profit patient-physician-industry alliance working toward a common goal of creating a world free of atrial fibrillation.

Dr. Lakkireddy is the associate editor for the reputable bimonthly online open access arrhythmia journal, the Journal of Atrial Fibrillation (www.jafib.com). He is the sitting governor for the Kansas Chapter of the American College of Cardiology (ACC).

See More

Patrick McCarthy, M.D.

Mitral valve therapy: the role of surgery in the era of percutaneous therapy
Friday, Sept. 8 | 2:40 p.m.

Dr. McCarthy is executive director of the Bluhm Cardiovascular Institute at Northwestern Medicine, the Heller-Sacks Professor of Surgery in the Feinberg School of Medicine and chief of cardiac surgery. He has distinguished himself as a clinician, researcher, educator and administrator in heart disease. Dr. McCarthy trained at the Mayo Clinic in general and cardiac surgery, at Stanford University for an advanced fellowship including heart and lung transplantation, and practiced at the Cleveland Clinic from 1990 until March 2004.

While there, he was the George and Linda Kaufman Chair of Surgery and surgical director of the Kaufman Center for Heart Failure as well as director of heart transplantation and mechanical circulatory support. Dr. McCarthy returned to his home in Chicago in 2004 when he was recruited to Northwestern. Dr. McCarthy has performed over 11,000 heart operations including approximately 6,000 heart valve surgeries. He has authored or co-authored more than 400 papers and 50 book chapters. He has been on the editorial board of eight medical journals and has been an officer in numerous professional societies. In 2008, he won the Socrates Award for teaching from the Thoracic Surgery Residents Association. Dr. McCarthy also has a joint appointment with the Department of Biomedical Engineering of Northwestern University due to his work educating young entrepreneurs (NUvention), and he has invented several medical products for clinical use.

From 2004 until 2016, the volume of cardiac surgery at Northwestern quadrupled under Dr. McCarthy’s leadership. Heart valve surgery, heart transplantation and mechanical support devices grew by more than 730 percent, and Northwestern became one of the largest heart valve surgery programs in the nation. The Northwestern heart and heart surgery program rapidly rose in the U.S. News & World Report rankings from unranked in 2006 to No. 6 in the U.S. in 2016. Over 1,200 physicians, nurses and support staff work in the Bluhm Cardiovascular Institute.

See More

Jeanie Poole, M.D.

Prevention of sudden cardiac death
Saturday, Sept. 9 | 11 a.m.

Dr. Poole focuses on the treatment and prevention of life threatening ventricular arrhythmias. She has participated in and led many clinical trials of implantable device therapy, including the NHLBI supported SCD-HeFT ICD-Electrogram (EGM) Core Lab, Home Automatic External Defibrillator Trial, Catheter Ablation vs. Antiarrhythmic Drug therapy in Atrial Fibrillation Trial (CABANA) and the upcoming MADIT-SICD trial. In addition, she completed an investigator initiated multicenter study examining complications related to pacemaker and ICD generator replacements (The REPLACE Registry). She has published extensively in cardiology and cardiac electrophysiology.

At the University of Washington, Dr. Poole served as Section Head, Electrophysiology and Arrhythmia Service since 2000 and was the Director of the CCEP fellowship from 2000-2015. She is responsible for growth of the UW electrophysiology services, hiring many faculty, staff and allied professionals through the years and advancing new infrastructure and program building. As CCEP director, she formed the EP training curriculum and had oversight of the program as it developed.

Dr. Poole has spoken at or served as a chair-person at major national and international cardiology and electrophysiology scientific conferences. She also served on many committees with the American College of Cardiology/American Heart Association or Heart Rhythm Society (HRS). She is Chair of the HRS Education Committee – where she has participated over 5 years – and was elected to the HRS Board of Trustees. Here, she launched the first full on-line educational curriculum on the Heart Rhythm Learning Center. Initially, an educational platform for allied professionals (2014-2015) was launched, then followed by Electrophysiology Pathways (2015-2016) products.

Other notable efforts include her tenure as Associate Editor for the Journal of the American College of Cardiology (JACC), and JACC-Clinical Electrophysiology and advocacy to support women to both choose electrophysiology as a career path and provide mentorship to many men and women in EP – both during their fellowship training and early faculty careers.

See More

Partho Sengupta, M.D., D.M., F.A.C.C., F.A.S.E.

Multimodality imaging in structural heart disease
Friday, Sept. 8 | 1:40 p.m.

Dr. Sengupta is a professor of cardiology, director of Cardiac Imaging and chair of Cardiac Innovations at the Heart and Vascular Institute, part of West Virginia Institute in Morgantown, West Virginia.


Clyde Yancy, M.D., M.Sc.

Chronic heart failure: integrating new therapies into clinical practice
Friday, Sept. 8 | 8:40 a.m.

Dr. Yancy is Chief of Cardiology at Northwestern University, Feinberg School of Medicine, and Associate Director of the Bluhm Cardiovascular Institute at Northwestern Memorial Hospital. He holds the Magerstadt Endowed Professor of Medicine Chair and also holds an appointment as Professor of Medical Social Sciences. He concurrently serves as Vice-Dean of Diversity & Inclusion, Northwestern University, Feinberg School of Medicine.